Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The renal peri-adventitial sympathetic nerves and adjacent perivascular tissue represent a key anatomical complex involved in the regulation of systemic blood pressure and renal function [1]. This target consists of a network of efferent and afferent nerve fibers located primarily within the adventitia of the renal arteries and the surrounding adipose tissue [2]. Efferent sympathetic activity at this site stimulates renin release, increases sodium reabsorption, and reduces renal blood flow, all of which contribute to hypertension [3]. Afferent fibers transmit signals from the kidney to the brain, driving a global increase in sympathetic tone that affects the heart and peripheral vasculature [4]. Pathological overactivation of these nerves is a hallmark of resistant hypertension, heart failure, and chronic kidney disease [5]. While systemic drugs like beta-blockers modulate sympathetic output, this specific tissue is the direct target of renal denervation (RDN) therapies [6]. RDN procedures employ radiofrequency, ultrasound, or chemical agents (such as ethanol) to ablate these nerves and disrupt the sympathetic feedback loop [7]. Clinical trials have demonstrated that targeting this tissue can significantly reduce blood pressure in patients who are non-responsive to conventional pharmacotherapy [8]. Safety concerns include potential damage to the renal artery wall, such as stenosis or dissection, during the ablation process [9]. Understanding the precise distribution of these nerves within the perivascular space is essential for optimizing the efficacy of neuromodulation devices [10].
Thermal or chemical ablation of sympathetic nerve fibers to reduce systemic sympathetic activity and lower blood pressure [6, 7].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Renal peri-adventitial sympathetic nerves and adjacent perivascular tissue (RSN).